BusinessJul 21, 2026Novo Nordisk Sues Eli Lilly Over AdvertisingNovo Nordisk filed a lawsuit accusing Eli Lilly of false advertising, alleging Lilly used outdated clinical trial data in marketing to make its drugs appear more eff...Novo NordiskEli Lilly
HealthMar 24, 2026FDA Approves Higher-Dose Wegovy (7.2 mg) for Adult Obesity; Trials Show Greater Weight Loss but Increased Side EffectsThe U.S. Food and Drug Administration has approved a new, higher-dose Wegovy (semaglutide) injection—Wegovy HD at 7.2 mg—for long-term weight loss and weight mainten...FDAWegovy (semaglutide)Novo Nordisk
HealthDec 23, 2025FDA approves Wegovy pill for weight lossThe U.S. Food and Drug Administration has approved an oral pill version of Wegovy, a widely used weight-loss drug, making it the first daily oral medication for obes...FDAWegovyObesity+2
BusinessJul 21, 2026Novo Nordisk sues Eli Lilly over advertsNovo Nordisk announced it is suing U.S. rival Eli Lilly, alleging that Lilly ran adverts that are “false and materially misleading.” Novo Nordisk claims Lilly “inten...Novo NordiskEli LillyWeight Loss
HealthFeb 24, 2026Novo Nordisk to slash Wegovy and Ozempic prices starting in 2027Novo Nordisk, a major pharmaceutical company, announced it will reduce the prices of its popular weight-loss and diabetes medications, Wegovy and Ozempic, by up to 5...Weight LossDiabetesNovo Nordisk+2
